Indian pharma – time for a cyclical upturn in US generics?
Due to absent competition, such drugs become huge cash cows for innovator companies. Titans in this space include companies like Gilead Sciences, J&J, Roche, Merck, Amgen, Pfizer, AbbVie, Novartis, and AstraZeneca, to name a few.
